logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Musculoskeletal Diseases Or Conditions

    FiltersReset Filters
    6 results

    • carisoprodol

      (carisoprodol)
      Wallace Pharmaceuticals Inc.
      Usage: Carisoprodol tablets are indicated for relieving discomfort from acute, painful musculoskeletal conditions in adults. They are recommended for short-term use only (up to two to three weeks) due to insufficient evidence for prolonged effectiveness and the typically short duration of such conditions.

    • cyclobenzaprine

      (cyclobenzaprine)
      Macleods Pharmaceuticals Limited
      Usage: Cyclobenzaprine hydrochloride extended-release capsules are indicated for short-term relief of muscle spasms associated with acute, painful musculoskeletal conditions, as an adjunct to rest and physical therapy. They are not effective for spasticity due to cerebral or spinal cord diseases or in children with cerebral palsy.

    • cyclobenzaprine hydrochloride

      (Cyclobenzaprine Hydrochloride)
      NORTHSTAR RX LLC
      Usage: Cyclobenzaprine hydrochloride tablets are indicated as an adjunct to rest and physical therapy for short-term relief of muscle spasms and associated symptoms in acute, painful musculoskeletal conditions. It is not effective for spasticity related to cerebral or spinal cord diseases or in children with cerebral palsy.

    • metaxalone

      (Metaxalone)
      Actavis Pharma, Inc.
      Usage: Metaxalone tablets are indicated for relieving discomfort associated with acute, painful musculoskeletal conditions in adults and pediatric patients aged 13 years and older, in conjunction with rest, physical therapy, and other supportive measures.

    • methocarbamol tablets, usp, 500 mg

      (Methocarbamol)
      Marlex Pharmaceuticals, Inc.
      Usage: Methocarbamol Tablets, USP are indicated as an adjunct treatment for relieving discomfort associated with acute, painful musculoskeletal conditions, alongside rest and physical therapy. Its precise mode of action is unclear, but it may involve sedative properties rather than direct muscle relaxation.

    • soma

      (Carisoprodol)
      Meda Pharmaceuticals Inc.
      Usage: SOMA is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. It should be used for short durations (up to three weeks) due to lack of evidence for longer-term effectiveness and the typically short duration of these conditions.